Skip to main content
. 2020 Jul 23;21(15):5238. doi: 10.3390/ijms21155238

Table 1.

IL-6 and IL-6R mAbs.

Biological Other Names Commercial Name Producer Target
Siltuximab Sylvant ** IL-6
Clazakizumab LD518 and BMS-945429 Adler Biopharma IL-6
Olokizumab UCB IL-6
Vobarilizumab Il-6R
Olamkicept FE-301; FE-999301; TJ-301 Ferring IL-6R
Sarilumab Kevzara Sanofi IL-6R
Sirukumab ** Janssen IL-6
Olamkicept Ferring
Satralizumab Sapelizumab, SA237 Roche IL-6R
Tocilizumab Tocilizumab, Actemra e RoActemra. Roche IL-6R

** this drug is approved for multicentric Castleman disease.